The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

REFERENCES

• Parrott AC. Drug-related harm: a complex and difficult concept to scale. Hum Psychopharmacol. 2007;22:423–425.
   Google Scholar
• Montoya AG, Sorrentino R, Lukas SE, Price BH. Long-term neuropsychiatric consequences of ‘ecstasy’ (MDMA), a review. Harv Rev Psychiatry. 2002;10:212–220.
   PubMed Web of Science ®Google Scholar
• Cowan RL. Neuroimaging research in human MDMA users: a review. Psychopharmacology. 2007;189:539–556.
   PubMed Web of Science ®Google Scholar
• Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol. 2006;20:164–175.
   Google Scholar
• Gouzoulis-Mayfrank E, Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol. 2006;20:188–193.
   PubMed Web of Science ®Google Scholar
• Medina KL, Shear PK. Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend. 2007;87:303–311.
   PubMed Web of Science ®Google Scholar
• Parrott AC. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol. 2006;20:147–163.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., Text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Koesters SC, Rogers PD, Rajasingham CR. MDMA (“ecstasy”) and other “club drugs.” The new epidemic. Pediatr Clin North Am. 2002;49:415–433.
   PubMed Web of Science ®Google Scholar
• Maxwell JC. Party drugs: properties, prevalence, patterns, and problems. Subst Use Misuse. 2005;40:1203–1240.
   PubMed Web of Science ®Google Scholar
• Patel MM, Wright DW, Ratcliff JJ, Miller MA. Shedding new light on the “safe” club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. Acad Emerg Med. 2004;11:208–210.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Club drugs, 2001 update. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2002.
   Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Overall, illicit drug use by American teens continues gradual decline in 2007. Ann Arbor, MI: University of Michigan News Service [online]; 2007. Available at: www.monitoringthefuture.org. Accessed March 30, 2008.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008.
   Google Scholar
• Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Various stimulant drugs show continuing gradual declines among teens in 2008, most illicit drugs hold steady. University of Michigan News Service: Ann Arbor, MI; 2008 http://www.monitoringthefuture.org/pressreleases/08drugpr.pdf. Accessed on March 23, 2009.
   Google Scholar
• Carlson RG, Wang J, Falck RS, Siegal HA. Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug Alcohol Depend. 2005;79:167–179.
   PubMed Web of Science ®Google Scholar
• Parrott AC. Human psychopharmacology of ecstasy (MDMA), a review of 15 years of empirical research. Human Psychopharmacol. 2001;16:557–577.
   PubMed Web of Science ®Google Scholar
• Strote J, Lee JE, Wechsler H. Increasing MDMA use among college students: results of a national survey. J Adolesc Health. 2002;30:64–72.
   PubMed Web of Science ®Google Scholar
• Wu LT, Schlenger WE, Galvin DM. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend. 2006;84:102–113.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Griffiths P, Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend. 2001;64:9–17.
   PubMed Web of Science ®Google Scholar
• Muthén B, Muthén LK. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol Clin Exp Res. 2000;24:882–889.
   PubMed Web of Science ®Google Scholar
• Wu LT, Blazer DG, Patkar AA, Stitzer ML, Wakim PG, Brooner RK. Heterogeneity of stimulant dependence: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Am J Addict. 2009;18:206–218.
   PubMed Web of Science ®Google Scholar
• Grant BF, Hasin DS, Stinson FS, . Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65:948–958.
   PubMed Web of Science ®Google Scholar
• Grant BF. The impact of a family history of alcoholism on the relationship between age at onset of alcohol use and DSM–IV alcohol dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Alcohol Health Res World. 1998;22:144–147.
   PubMed Web of Science ®Google Scholar
• Hser YI, Anglin MD, Grella C, Longshore D, Prendergast ML. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse Treat. 1997;14:543–558.
   PubMed Web of Science ®Google Scholar
• Keyes KM, Martins SS, Hasin DS. Past 12-month and lifetime comorbidity and polydrug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2008;97:139–149.
   Google Scholar
• Wu LT, Ringwalt CL, Mannelli P, Patkar AA. Hallucinogen use disorders among adult users of MDMA and other hallucinogens. Am J Addict. 2008;17:354–363.
   Web of Science ®Google Scholar
• Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorders and Associated Disabilities Interview Schedule–IV (AUDADIS IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71:7–16.
   PubMed Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatr. 2004;61:807–816.
   PubMed Web of Science ®Google Scholar
• Wu LT, Howard MO, Pilowsky DJ. Substance use disorders among inhalant users: results from the National Epidemiologic Survey on alcohol and related conditions. Addict Behav. 2008;33:968–973.
   PubMed Web of Science ®Google Scholar
• Research Triangle Institute. SUDAAN user’s manual, release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2006.
   Google Scholar
• Muthén BO, Muthén LK. Mplus: Statistical analysis with latent variables (version 4.2.1). Los Angeles, CA: Muthén and Muthén, Inc.; 2007.
   Google Scholar
• Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13:195–212.
   Web of Science ®Google Scholar
• Nylund KL, Asparouhov T, Muthén B. Deciding on the number of classes in latent class analysis and growth mixture modeling. A Monte Carlo simulation study. Struct Equ Model. 2007;14:535–569.
   Web of Science ®Google Scholar
• Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res. 2001;16:457–469.
   PubMed Web of Science ®Google Scholar
• Parrott AC. Chronic tolerance to recreational MDMA 3,4– methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol. 2005;19:71–83.
   PubMed Web of Science ®Google Scholar
• Parrott AC, Morinan A, Moss M, Scholey A. Understanding drugs and behaviour. Chichester: Wiley; 2004.
   Google Scholar
• Koob GF, Le Moal M. The neurobiology of addiction. Elsevier, MA: Academic Press; 2006.
   Google Scholar
• Soar K, Turner JJ, Parrott AC. Psychiatric disorders in ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history. Hum Psychopharmacol. 2001;16:641–645.
   PubMed Web of Science ®Google Scholar
• Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A. Mental disorders in current and former heavy ecstasy (MDMA) users. Addiction. 2005;100:1310–1319.
   PubMed Web of Science ®Google Scholar
• Jessor R. New perspectives on adolescent risk behavior. In: Jessor R, ed. New perspectives on adolescent risk behavior. Cambridge, United Kingdom: Cambridge University Press; 1998: 1–10.
   Google Scholar
• McGue M, Iacono WG. The association of early adolescent problem behavior with adult psychopathology. Am J Psychiatry. 2005;162:1118–1124.
   PubMed Web of Science ®Google Scholar
• Newcomb MD, Felix-Ortiz M. Multiple protective and risk factors for drug use and abuse: cross-sectional and prospective findings. J Pers Soc Psychol. 1992;63:280–296.
   PubMed Web of Science ®Google Scholar
• Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol. 2001;11:250–257.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Bredin E, . A family study of the high-risk children of opioid- and alcohol-dependent parents. Am J Addict. 2002;11:41–51.
   PubMed Web of Science ®Google Scholar
• Topp L, Hando J, Dillon P, Roche A, Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999;55:105–115.
   PubMed Web of Science ®Google Scholar
• Brick J. Handbook of the medical consequences of alcohol and drug abuse. New York: The Haworth Press; 2004.
   Google Scholar
• Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm. 2007;114:959–968.
   PubMed Web of Science ®Google Scholar
• Thomasius R, Zapletalova P, Petersen K, . Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol. 2006;20:211–225.
   PubMed Web of Science ®Google Scholar
• SB Hamida, A Tracqui, AP de Vasconcelos. Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA. Int J Neuropsychopharmacol. 2008; 1–11.
   Google Scholar
• Izco M, Orio L, O’Shea E, Colado MI. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology (Berl). 2007;189:459–470.
   PubMed Web of Science ®Google Scholar
• Klitzman RL, Pope HG Jr, Hudson JI. MDMA (“ecstasy”) abuse and high-risk sexual behaviors among 169 gay and bisexual men. Am J Psychiatry. 2000;157:1162–1164.
   PubMed Web of Science ®Google Scholar
• Klitzman RL, Greenberg JD, Pollack LM, Dolezal C. MDMA (“ecstasy”) use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City. Drug Alcohol Depend. 2002;66:115–125.
   PubMed Web of Science ®Google Scholar
• Parrott AC, Milani RM, Parmar R, Turner JJD. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology. 2001;159:77–82.
   PubMed Web of Science ®Google Scholar
• Wu LT, Parrott AC, Ringwalt CL, Patkar AA, Mannelli P, Blazer DG. The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. Addict Behav. 2009;34:654–661.
   PubMedGoogle Scholar